BiyaPay analyst: A 600-fold increase in half a year! Is the "MM Coin" in the US stock market an opportunity or a bubble?

On July 16, BiyaPay analysts stated that Nasdaq-listed Regenerative Genetics Corporation (RGC) saw its stock price surge 642 times in half a year, resembling an "American stock version of MM coin". If one invested $10,000 at the beginning of the year, the market value would now exceed $6 million, which is shocking. This Hong Kong-based company, previously considered a "penny stock", has only 12 employees and has had no revenue from 2021 to date. Research and development investment has been declining year after year, with only $1.07 million in 2024. The company has been rumored to have its chip approved by the FDA and planning to collaborate with Mayo Clinic, but this information has not been found in official websites or regulatory disclosures. Regenerative's products are based on traditional Chinese medicine treatments for ADHD and ASD, with clinical trials lacking a control group and lacking credible evaluation standards. Additionally, the company reduced stock price thresholds through a 38:1 stock split and drove stock price surge with extremely low circulating stocks, demonstrating sophisticated capital operation techniques. Shareholder structure reveals that the company's founder and "Taiwan's version of Warren Buffett" Chen Xianzhe collectively hold over 93% of shares, with extremely low market liquidity, making the stock price easily manipulated. Behind this surge, is it an opportunity or a speculative pass-the-parcel game? Investors need to remain calm and rational. BiyaPay analysts suggest that users can use USDT to trade US and Hong Kong stocks in real-time without applying for offshore accounts, conveniently participating in global market investments while ensuring flexibility and fund safety. Rather than chasing hot spots, it's better to choose compliant platforms for steady progress.